KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rigel Pharmaceuticals (RIGL) Shares Outstanding (Diluted Average) (2019 - 2025)

Historic Shares Outstanding (Diluted Average) for Rigel Pharmaceuticals (RIGL) over the last 11 years, with Q3 2025 value amounting to $19.2 million.

  • Rigel Pharmaceuticals' Shares Outstanding (Diluted Average) rose 854.49% to $19.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.2 million, marking a year-over-year increase of 854.49%. This contributed to the annual value of $17.7 million for FY2024, which is 164.36% up from last year.
  • Latest data reveals that Rigel Pharmaceuticals reported Shares Outstanding (Diluted Average) of $19.2 million as of Q3 2025, which was up 854.49% from $18.2 million recorded in Q2 2025.
  • Rigel Pharmaceuticals' 5-year Shares Outstanding (Diluted Average) high stood at $176.5 million for Q3 2021, and its period low was $17.0 million during Q4 2022.
  • For the 5-year period, Rigel Pharmaceuticals' Shares Outstanding (Diluted Average) averaged around $83.4 million, with its median value being $18.2 million (2025).
  • Per our database at Business Quant, Rigel Pharmaceuticals' Shares Outstanding (Diluted Average) tumbled by 9000.01% in 2022 and then soared by 854.49% in 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Shares Outstanding (Diluted Average) (Quarter) stood at $170.5 million in 2021, then tumbled by 90.0% to $17.0 million in 2022, then increased by 2.06% to $17.4 million in 2023, then increased by 1.64% to $17.7 million in 2024, then increased by 8.31% to $19.2 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $19.2 million in Q3 2025, compared to $18.2 million in Q2 2025 and $18.2 million in Q1 2025.